ENVA
Enova International, Inc.
ENVA has a slight edge over MS overall, supported by stronger modeled upside.
MS
Morgan Stanley
MS has lower modeled downside risk, despite its lower overall score.
ENVA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
ENVA's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ENVA.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
ENVA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.1x | $73.60 | -56% |
| Forward | 8.3x | $167 | — |
| Fair | 9.9x | $143 | -14% |
| Current | 12x | $167 | — |
| Expensive | 15x | $218 | +31% |
Historical ranges are pointers, not guarantees.
ENVA's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 8.3x next year's earnings.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over ENVA in the historical PE scenario, which offers more potential upside but is not a forecast.
ENVA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for ENVA, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
ENVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.18 | +40% |
| Q3 2026 | $14.46 | +33% |
| Q2 2026 | $13.43 | +43% |
| Q1 2026 | $12.29 | +45% |
| Q4 2025 | $11.52 | +55% |
| Q3 2025 | $10.87 | +73% |
| Q2 2025 | $9.41 | +57% |
| Q1 2025 | $8.48 | +52% |
| Q4 2024 | $7.43 | +35% |
ENVA has the edge over MS on earnings, with stronger typical year-over-year growth.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
ENVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1B | +26% |
| Q2 2026 | $928.9M | +22% |
| Q1 2026 | $875.1M | +17% |
| Q4 2025 | $839.4M | +15% |
| Q3 2025 | $802.7M | +16% |
| Q2 2025 | $764M | +22% |
| Q1 2025 | $745.5M | +22% |
| Q4 2024 | $729.6M | +25% |
ENVA has the edge over MS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 25% | 0 points |
| Q2 2026 | 26% | +1.4 points |
| Q1 2026 | 24% | +0.6 points |
| Q4 2025 | 22% | +1 points |
| Q3 2025 | 25% | +2.2 points |
| Q2 2025 | 24% | +1 points |
| Q1 2025 | 23% | +1.6 points |
| Q4 2024 | 21% | +4.6 points |
ENVA's operating margin was 25% last quarter, about level with the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over ENVA on profitability, with a higher operating margin.
ENVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $524M | +11% |
| Q2 2026 | $531.4M | +22% |
| Q1 2026 | $463.8M | +23% |
| Q4 2025 | $487.1M | +16% |
| Q3 2025 | $470.5M | +21% |
| Q2 2025 | $436.1M | +25% |
| Q1 2025 | $378.3M | +12% |
| Q4 2024 | $420.3M | +39% |
ENVA has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
ENVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +160K shares |
| 1 year | -0.1% | -38K shares |
| 3 years | -17% | -5.5M shares |
| 5 years | -30% | -11.6M shares |
| Available history | -23% | -7.7M shares |
ENVA has 26M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $46.3M |
| Q2 2026 | $19.8M |
| Q1 2026 | $39.6M |
| Q4 2025 | $35.3M |
| Q3 2025 | $38.4M |
| Q2 2025 | $55.3M |
| Q1 2025 | $85.5M |
| Q4 2024 | $51.2M |
ENVA spent $141M buying back its own shares over the past year, down 39% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over ENVA on shareholder dilution, with a more favorable share count trend.
ENVA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.8x | High |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 5.8x | High |
| Q4 2025 | 5.7x | High |
| Q3 2025 | 5.4x | High |
| Q2 2025 | 5.5x | High |
| Q1 2025 | 5.6x | High |
| Q4 2024 | 5.6x | High |
ENVA has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
ENVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.9 | Neutral |
| Stochastic | 7.6 | Oversold |
ENVA's weekly RSI is 40 (neutral) and its Stochastic is 8 (oversold).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
ENVA PE vs Financial Services Sector
| Metric | ENVA | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 11% below |
| PE % | 61 | 63 | 2 pts below |
ENVA has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
ENVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $172.6 | 3.2% below |
| 20 week MA | $210.0 | 20% below |
| 50 week MA | $179.9 | 7.1% below |
| 100 week MA | $143.1 | 17% above |
| 200 week MA | $101.7 | 64% above |
ENVA has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 64% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over ENVA on trend strength, trading above more of its moving averages.
ENVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.4 | $25.8 | +10% |
| 2021 | $25.8 | $40.4 | +57% |
| 2022 | $40.4 | $38.3 | -5.1% |
| 2023 | $38.3 | $55.4 | +44% |
| 2024 | $55.4 | $97.9 | +77% |
| 2025 | $97.9 | $164.8 | +68% |
| 2026 YTD | $164.8 | $167.0 | +1.3% |
ENVA has finished higher in five of the last six years, three of them by more than 50%. It's up 1.3% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over ENVA on returns for 2026, with the stronger performance.